Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-10-22
2010-10-19
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S272000, C514S252140, C514S344000, C514S245000, C514S262100, C514S302000, C544S321000, C544S122000, C544S238000, C544S295000, C544S262000, C546S288000, C546S115000
Reexamination Certificate
active
07816353
ABSTRACT:
Compounds of formula III:wherein R5a, R3, X, Y, Q, R1aand R1bare as defined in the specification, pharmaceutically acceptable salts thereof, and methods of use thereof.
REFERENCES:
patent: 2354505 (1944-07-01), D Alelio et al.
patent: 3470183 (1969-09-01), Roth
patent: 3670077 (1972-06-01), Freeman et al.
patent: 5017701 (1991-05-01), Grinter et al.
patent: 5502187 (1996-03-01), Ayer et al.
patent: 5837708 (1998-11-01), Breu et al.
patent: 5939462 (1999-08-01), Connell et al.
patent: 6031072 (2000-02-01), Blaschuk et al.
patent: 6107297 (2000-08-01), Kindon et al.
patent: 6107301 (2000-08-01), Aldrich et al.
patent: 6303618 (2001-10-01), Griffin et al.
patent: 6849631 (2005-02-01), Carini
patent: 7176310 (2007-02-01), Baughman et al.
patent: 2003/0053366 (2003-03-01), Lee
patent: 2003/0204083 (2003-10-01), Giencke et al.
patent: 2007/0155739 (2007-07-01), Sucholeiki et al.
patent: 2007/0249578 (2007-10-01), Inghardt et al.
patent: 2547691 (1976-04-01), None
patent: 635582 (1950-04-01), None
patent: 763041 (1956-12-01), None
patent: 51052184 (1976-05-01), None
patent: 63122684 (1988-05-01), None
patent: 2001139472 (2001-05-01), None
patent: 2002037787 (2002-02-01), None
patent: 2003221337 (2003-08-01), None
patent: WO 9724122 (1997-07-01), None
patent: WO 9809960 (1998-03-01), None
patent: WO 9835944 (1998-09-01), None
patent: WO 9843968 (1998-10-01), None
patent: WO 0020393 (2000-04-01), None
patent: WO 0192264 (2001-12-01), None
patent: WO 03048164 (2003-06-01), None
patent: WO 03048165 (2003-06-01), None
patent: WO 2005030734 (2005-04-01), None
patent: WO 2005033072 (2005-04-01), None
Font, et al., Journal of Combinatorial Chemistry (2003), 5(3), 311-321.-HAVE.
Baraldi, et al., Bioorganic & Medicinal Chemistry (2003), 11(19), 4161-4169.-HAVE.
Sasaki, et al., Bioorganic & Medicinal Chemistry Letters (2002), 12(16), 2073-2077.-HAVE.
El-Tombary, et al., Farmaco (1999), 54(7), 486-495-HAVE.
Hardy, et al., Experimental Parasitology (1997), 87(3), 157-169.-have.
Jantova, et al., Folia Biologica (Prague) (1997), 43(2), 83-89.
Abd El-Fattah, Indian Journal of Heterocyclic Chemistry (1995), 4(3), 199-202.
Ismail, Journal of the Serbian Chemical Society (1994), 59(6), 353-8.
Spirkova, et al., Collection of Czechoslovak Chemical Communications (1994), 59(1), 222-6.
Cocco, et al., Journal of Heterocyclic Chemistry (1992), 29(5), 1341-7.
Temple, et al., Journal of Medicinal Chemistry (1992), 35(26), 4809-12.
Ogawa, et al., Chemical & Pharmaceutical Bulletin (1992), 40(5), 1315-17.
Seada, et al., Asian Journal of Chemistry (1992), 4(3), 604-14.
Ogawa, et al., Chemical & Pharmaceutical Bulletin (1992), 40(2), 343-50.
Harnden, et al., Australian Journal of Chemistry (1990), 43(1), 55-62.
Youssef, Egyptian Journal of Pharmaceutical Sciences (1989), 30(1-4), 465-72.
Hurst, et al., Australian Journal of Chemistry (1988), 41(8), 1209-19.
Bailey, et al., Biochemistry (1989), 28(2), 494-504.
Sharanin, et al., Khimiya Geterotsiklicheskikh Soedinenii (1987), (10), 1377-84.
Nohara, et al., Tetrahedron Letters (1987), 28(12), 1287-90.
Dunaev, et al., Khimiko-Farmatsevticheskii Zhurnal (1986), 20(10), 1198-202.
Nair, et al., Journal of Organic Chemistry (1981), 46(16), 3354-7.
Vasilev, et al., Doklady Bolgarskoi Akademii Nauk (1980), 33(6), 849-51.
Roth, et al., Journal of Organic Chemistry (1980), 45(18), 3651-7.
Walsh, et al., Journal of Chemical Research, Synopses (1980), (2), 38-9.
Vorbrueggen, et al., Angewandte Chemie (1976), 88(21), 724-5.
Pfleiderer, et al., Chemische Berichte (1971), 104(7), 2293-2312.
Roth, Journal of Medicinal Chemistry (1969), 12(2), 227-32.
Pfleiderer, et al., Chemische Berichte (1966), 99(9), 3008-21.
Polya, et al., Journal of the Chemical Society, (Dec. 1964), 4986-92.
Noell, et al., Journal of Medicinal & Pharmaceutical Chemistry (1962), 5, 1074-85.
Davis, et al., Journal of the American Chemical Society (1960), 82, 2633-40.
Bell, et al., Journal of the American Chemical Society (1960), 82, 1469-71.
Boon, et al., Journal of the Chemical Society (1957) 2146-58.
Kilroe Smith, et al., Tetrahedron (1957), 1, 38-44.
Boon, et al., Journal of the Chemical Society (1951) 591-6.
Wikipedia, Sirolimus, updated Feb. 28, 2009, <http://en.wikipedia.org/wiki/Sirolimus>, downloaded Mar. 19, 2009.
Sawyers, et al., Nature Reviews—Cancer, Mar. 2008, vol. 8.
Gomez-Cambronero, et al., J. Immunology, 2003, 6846-6855.
Buset, et al., Canc. Res. 46, 5426-5430, Oct. 1986.
Eidelberg, et al., Brain (1997), 120, 1315-1324.
Mackie, et al., J. Clinical Endocrinology & Metabolism 91(7):2665-2671, 2006.
McDermott, et al., Brit. J. Surgery, vol. 77, #10, 1179-1182, 2005.
Cheng Wei
Co Erick Wang
Kim Moon Hwan
Klein Rhett Ronald
Le Donna T.
Exelixis Inc.
Jaisle Cecilia M
McDonnell Boehnen & Hulbert & Berghoff LLP
Wilson James O
LandOfFree
P70S6 kinase modulators and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P70S6 kinase modulators and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P70S6 kinase modulators and method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4217072